Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy
Completed
Duchesnay Inc.
Phase 3
2006-02-01
The purpose of this study is to determine whether pre-emptive use of a delayed release
combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before
eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will
reduce the incidence of severe forms of this syndrome/HG.
Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy
Completed
The Hospital for Sick Children
Phase 3
2006-02-01
The purpose of this study is to determine whether pre-emptive use of a delayed release
combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before
eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will
reduce the incidence of severe forms of this syndrome/HG.
The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy
Completed
Premier Research Group plc
Phase 3
2008-01-01
The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg
and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of
pregnancy than a placebo.
The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy
Completed
Duchesnay Inc.
Phase 3
2008-01-01
The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg
and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of
pregnancy than a placebo.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
